O
CYNA

OrbiMed’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

OrbiMed’s Portfolio CYNA Stock Details CYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-499,999
Closed -$20.1M – 150
2016
Q3 		$20.1M Sell
499,999
-640,326
-56% -$15.8M 0.23% 74
2016
Q2 		$17.5M Hold
1,140,325
– – 0.18% 77
2016
Q1 		$13.2M Hold
1,140,325
– – 0.14% 77
2015
Q4 		$17.6M Hold
1,140,325
– – 0.16% 72
2015
Q3 		$18.4M Hold
1,140,325
– – 0.19% 76
2015
Q2 		$23.3M Buy
+1,140,325
New +$18.7M 0.19% 79

OrbiMed's CYNA Position: Q4 2016 in Review

OrbiMed sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 499,999 shares — an estimated $20.1M sold.

OrbiMed first reported a position in CYNA in Q2 2015 and held it in 6 quarters. The position peaked at $23.3M in Q2 2015. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

  • OrbiMed reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
  • OrbiMed sold 499,999 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $20.1M.
  • OrbiMed first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q2 2015 and held it in 6 quarters.
  • OrbiMed's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $23.3M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on OrbiMed's 13F filing for Q4 2016, filed 14 Feb 2017.